Hepatopulmonary syndrome

Current Opinion in Gastroenterology

Volumn 30, Issue 3, 2014, Pages 260-264

  Koch, David G ^a   Fallon, Michael B ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

hepatopulmonary syndrome; hypoxemia; intrapulmonary vasodilatation; liver transplantation; portal hypertension

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SORAFENIB;

AMBIENT AIR; ANGIOGENESIS; ECHOCARDIOGRAPHY; GRAFT SURVIVAL; HEPATOPULMONARY SYNDROME; HUMAN; LIVER TRANSPLANTATION; LUNG SCINTISCANNING; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; ANIMAL; ANOXIA; COMPLICATION; DISEASE MODEL; PROGNOSIS;

ANIMALS; ANOXIA; DISEASE MODELS, ANIMAL; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; PROGNOSIS;

EID: 84898543854     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000067     Document Type: Review

References (50)

1. Abrams GA, Jaffe CC, Hoffer PB, et al. Diagnostic utility of contrast echo-cardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109:1283-1288.
2. Schenk P, Fuhrmann V, Madl C, et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002; 51:853-859.
3. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24:861-880.
4. Abrams GA, Nanda NC, Dubovsky EV, et al. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998; 114:305-310.
5. Martinez G, Barbera JA, Navasa M, et al. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 1999; 30:882-889.
6. Regev A, Yeshurun M, Rodriguez M, et al. Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat 2001; 8:83-86.
7. Teuber G, Teupe C, Dietrich CF, et al. Pulmonary dysfunction in noncirrhotic patients with chronic viral hepatitis. Eur J Intern Med 2002; 13:311-318.
8. Sari S, Oguz D, Sucak T, et al. Hepatopulmonary syndrome in children with cirrhotic and noncirrhotic portal hypertension: a single-center experience. Dig Dis Sci 2012; 57:175-181.
9. Gupta D, Vijaya DR, Gupta R, et al. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol 2001; 96:3395-3399.
10. De BK, Sen S, Biswas PK, et al. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenter-ology 2002; 122:897-903.
11. Krowka MJ. Hepatopulmonary syndrome and extrahepatic vascular abnormalities. Liver Transpl 2001; 7:656-657.
12. Fallon MB, Abrams GA, Luo B, et al the role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 113:606-614.
13. Fallon MB, Abrams GA, McGrath JW, et al. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol 1997; 272:G779-G784.
14. Zhang J, Ling Y, Luo B, et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003; 125:1441-1451.
15. Zhang M, Luo B, Chen SJ, et al. Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 1999; 277:G944-G952.
16. Zhang X, Katsuta Y, Akimoto T, et al. Intrapulomnary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct dilation. J Hepatol 2003; 39:724-730.
17. Katsuta Y, Zhang XJ, Ohsuga M, et al. Arterial hypoxemia and intrapulmonary vasodilatation in rat models of portal hypertension. J Gastroenterol 2005; 40:811-819.
18. Lee KN, Yoon SK, Lee JW, et al. Hepatopulmonary syndrome induced by common bile duct ligation in a rabbit model: correlation between pulmonary vascular dilatation on thin-section CT and angiography and serum nitrite concentration or endothelial nitric oxide synthase (eNOS)1 expression. Korean J Radiol 2004; 5:149-156.
19. Liu M, Tian D, Wang T, et al. Correlation between pulmonary endothelin receptors and alveolar-arterial oxygen gradient in rats with hepatopulmonary syndrome. J Huazhong Univ Sci Technol Med Sci 2005; 25:494-496.
20. Zhang XJ, Katsuta Y, Akimoto T, et al. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol 2003; 39:724-730.
21. Ling Y, Zhang J, Luo B, et al the role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 2004; 39:1593-1602.
22. Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998; 29:571-578.
23. Luo B, Liu L, Tang L, et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003; 38:556-563.
24. Luo B, Tang L, Wang Z, et al. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. Gastroenterology 2005; 129:682-695.
25. Luo B, Tang L, Zhang J, et al. Biliary epithelium derived endothelin-1: an endocrine mediator of experimental hepatopulmonary syndrome. Hepatology 2004; 40:214A.
26. Koch DG, Bogatkevich G, Ramshesh V, et al. Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans. Dig Dis Sci 2012; 57:516-523.
27. Zhang J, Yang W, Luo B, et al the role of CX(3)CL1/CX(3)CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol 2012; 57:752-758.
28. Liu L, Liu N, Zhao Z, et al. TNF-alpha neutralization improves experimental hepatopulmonary syndrome in rats. Liver Int 2012; 32:1018-1026.
29. Chang CC, Chuang CL, Lee FY, et al. Sorafenib treatment improves hepa-topulmonary syndrome in rats with biliary cirrhosis. Clin Sci (Lond) 2013; 124:457-466.
30. Yang W, Zhang J, Hu B, et al the role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepato-pulmonary syndrome. Am J Physiol Gastrointest Liver Physiol 2014; 306:G72-G80.
31. Yi B, Zeng J, Wang G, et al. Annexin A1 protein regulates the expression of PMVEC cytoskeletal proteins in CBDL rat serum-induced pulmonary micro-vascular remodeling. J Transl Med 2013; 11:98.
32. Zeng J, Yi B, Wang Z, et al. Effect of annexin A2 on hepatopulmonary syndrome rat serum-induced proliferation of pulmonary arterial smooth muscle cells. Respir Physiol Neurobiol 2013; 185:332-338.
33. Gaio E, Amado V, Rangel L, et al. Levofloxacin decreased chest wall mechanical inhomogeneities and airway and vascular remodeling in rats with induced hepatopulmonary syndrome. Respir Physiol Neurobiol 2013; 189:565-570.
34. Kianifar HR, Khalesi M, Mahmoodi E, Afzal Aghaei M. Pentoxifylline in hepatopulmonary syndrome. World J Gastroenterol 2012; 18:4912-4916.
35. Moreira Silva H, Reis G, Guedes M, et al. A case of hepatopulmonary syndrome solved by mycophenolate mofetil (an inhibitor of angiogenesis and nitric oxide production). J Hepatol 2013; 58:630-633.
36. Gupta S, Castel H, Rao RV, et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant 2010; 10:354-363.
37. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome:impact of liver transplantation. Hepatology 2005; 41:1122-1129.
38. Iyer VN, Swanson KL, Cartin-Ceba R, et al. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology 2013; 57:2427-2435.
39. Corley DA, Scharschmidt B, Bass N, et al. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology 1997; 113:728-730.
40. Allgaier HP, Haag K, Ochs A, et al. Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS). J Hepatol 1995; 23:102.
41. Benitez C, Arrese M, Jorquera J, et al. Successful treatment of severe hepatopulmonary syndrome with a sequential use of TIPS placement and liver transplantation. Ann Hepatol 2009; 8:71-74.
42. Chevallier P, Novelli L, Motamedi JP, et al. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year follow-up. J Vasc Interv Radiol 2004; 15:647-648.
43. Paramesh AS, Husain SZ, Shneider B, et al. Improvement ofhepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr Transplant 2003; 7:157-162.
44. Lasch HM, Fried MW, Zacks SL, et al. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 2001; 7:147-149.
45. Martinez-Palli G, Drake BB, Garcia-Pagan JC, et al. Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome. World J Gastroenterol 2005; 11:6858-6862.
46. Riegler JL, Lang KA, Johnson SP, Westerman JH. Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterology 1995; 109:978-983.
47. Selim KM, Akriviadis EA, Zuckerman E, et al. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol 1998; 93:455-458.
48. Nistal MW, Pace A, Klose H, et al. Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shunt. Thorax 2013; 68:889-890.
49. Wallace MC, James AL, Marshall M, Kontorinis N. Resolution of severe hepato-pulmonary syndrome following transjugular portosystemic shunt procedure. BMJ Case Rep 2012; 2012:.
50. Goldberg DS, Krok K, Batra S, et al. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver trans plantation: an analysis of the UNOS database. Gastroenterology 2014. (In press).